
RCM Technologies, Inc. Announces Third Quarter Results
Tables to Follow | ||||||
RCM Technologies, Inc. Condensed Consolidated Statements of Operations (Unaudited) (In Thousands, Except Per Share Amounts) | ||||||
Thirteen Weeks Ended | ||||||
September 28, 2024 | September 30, 2023 | |||||
Revenue | $60,365 | $58,049 | ||||
Cost of services | 42,524 | 40,768 | ||||
Gross profit | 17,841 | 17,281 | ||||
Selling, general and administrative | 13,018 | 12,662 | ||||
Depreciation and amortization of property and equipment | 393 | 243 | ||||
Amortization of acquired intangible assets | 45 | 45 | ||||
Operating income | 4,385 | 4,331 | ||||
Other expense, net | 619 | 141 | ||||
Income before income taxes | 3,766 | 4,190 | ||||
Income tax expense | 1,020 | 434 | ||||
Net income | $2,746 | $3,756 | ||||
Diluted net earnings per share data | $0.35 | $0.46 | ||||
Diluted weighted average shares outstanding | 7,789,446 | 8,196,330 |
Thirty-Nine Weeks Ended | ||||||
September 28, 2024 | September 30, 2023 | |||||
Revenue | $201,468 | $192,209 | ||||
Cost of services | 143,259 | 137,144 | ||||
Gross profit | 58,209 | 55,065 | ||||
Selling, general and administrative | 40,762 | 38,782 | ||||
Depreciation and amortization of property and equipment | 1,012 | 756 | ||||
Amortization of acquired intangible assets | 136 | 136 | ||||
Costs associated with potential stock issuance | 259 | - | ||||
Gain on sale of assets | - | (395 | ) | |||
Operating income | 16,040 | 15,786 | ||||
Other expense, net | 1,619 | 965 | ||||
Income before income taxes | 14,421 | 14,821 | ||||
Income tax expense | 3,961 | 3,245 | ||||
Net income | $10,460 | $11,576 | ||||
Diluted net earnings per share data | $1.31 | $1.33 | ||||
Diluted weighted average shares outstanding | 7,990,238 | 8,730,998 | ||||
RCM Technologies, Inc. Supplemental Operating Results on a Non-GAAP Basis (Unaudited) (In Thousands) |
The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures (“Adjusted operating income,”“EBITDA,”“Adjusted EBITDA,”“Adjusted net income” and“Adjusted diluted net earnings per share”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors' overall understanding of our current financial performance and period-to-period comparisons. Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share should not be considered alternatives to operating income or net income, as the case may be, as an indicator of performance. In addition, Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.
The following unaudited table presents the Company's GAAP operating income and GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share for the thirteen and thirty-nine weeks ended September 28, 2024 and September 30, 2023.
Thirteen Weeks Ended | Thirty-Nine Weeks Ended | |||||||||||
September 28, 2024 | September 30, 2023 | September 28, 2024 | September 30, 2023 | |||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||
GAAP operating income | $4,385 | $4,331 | $16,040 | $15,786 | ||||||||
Adjustments | ||||||||||||
Gain on sale of assets | - | - | - | (395 | ) | |||||||
Costs associated with potential stock issuance | - | - | 259 | - | ||||||||
Equity compensation | 767 | 484 | 2,154 | 1,451 | ||||||||
Adjusted operating income (non-GAAP) | $5,152 | $4,815 | $18,453 | $16,842 | ||||||||
GAAP net income | $2,746 | $3,756 | $10,460 | $11,576 | ||||||||
Income tax expense | 1,020 | 434 | 3,961 | 3,245 | ||||||||
Interest expense, net | 492 | 185 | 1,551 | 970 | ||||||||
Depreciation of property and equipment | 393 | 243 | 1,012 | 756 | ||||||||
Amortization of acquired intangible assets | 45 | 45 | 136 | 136 | ||||||||
EBITDA (non-GAAP) | $4,696 | $4,663 | $17,120 | $16,683 | ||||||||
Adjustments | ||||||||||||
Gain on sale of assets | - | - | - | (395 | ) | |||||||
Costs associated with potential stock issuance | - | - | 259 | - | ||||||||
Loss (gain) on foreign currency transactions | 127 | (44 | ) | 68 | (5 | ) | ||||||
Equity compensation | 767 | 484 | 2,154 | 1,451 | ||||||||
Adjusted EBITDA (non-GAAP) | $5,590 | $5,103 | $19,601 | $17,734 |
RCM Technologies, Inc. Supplemental Operating Results on a Non-GAAP Basis (Continued) (Unaudited) (In Thousands) | ||||||||||||
Thirteen Weeks Ended | Thirty-Nine Weeks Ended | |||||||||||
September 28, 2024 | September 30, 2023 | September 28, 2024 | September 30, 2023 | |||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||
GAAP net income | $2,746 | $3,756 | $10,460 | $11,576 | ||||||||
Adjustments | ||||||||||||
Gain on sale of assets | - | - | - | (395 | ) | |||||||
Costs associated with potential stock issuance | - | - | 259 | - | ||||||||
Loss (gain) on foreign currency transactions | 127 | (44 | ) | 68 | (5 | ) | ||||||
Equity compensation | 767 | 484 | 2,154 | 1,451 | ||||||||
Tax impact from normalized rate | (190 | ) | (138 | ) | (674 | ) | (295 | ) | ||||
Adjusted net income (non-GAAP) | $3,450 | $4,058 | $12,267 | $12,332 | ||||||||
GAAP diluted net earnings per share | $0.35 | $0.46 | $1.31 | $1.33 | ||||||||
Adjustments | ||||||||||||
Gain on sale of assets | ($0.04 | ) | ||||||||||
Costs associated with potential stock issuance | - | - | $0.03 | - | ||||||||
Loss (gain) on foreign currency transactions | $0.01 | - | $0.01 | - | ||||||||
Equity compensation | $0.10 | $0.06 | $0.27 | $0.16 | ||||||||
Tax impact from normalized rate | ($0.02 | ) | ($0.02 | ) | ($0.08 | ) | ($0.04 | ) | ||||
Adjusted diluted net earnings per share (non-GAAP) | $0.44 | $0.50 | $1.54 | $1.41 |
RCM Technologies, Inc. Summary of Selected Income Statement Data (Unaudited) (In Thousands) | ||||||||||||
Thirteen Weeks Ended September 28, 2024 | ||||||||||||
Specialty Health Care | Engineering | Life Sciences and IT | Consolidated | |||||||||
Revenue | $26,554 | $24,167 | $9,644 | $60,365 | ||||||||
Cost of services | 18,271 | 18,273 | 5,980 | 42,524 | ||||||||
Gross profit | 8,283 | 5,894 | 3,664 | 17,841 | ||||||||
Gross profit margin | 31.2 | % | 24.4 | % | 38.0 | % | 29.6 | % |
Thirteen Weeks Ended September 30, 2023 | ||||||||||||
Specialty Health Care | Engineering | Life Sciences and IT | Consolidated | |||||||||
Revenue | $24,895 | $22,452 | $10,702 | $58,049 | ||||||||
Cost of services | 17,438 | 16,846 | 6,484 | 40,768 | ||||||||
Gross profit | $7,457 | $5,606 | $4,218 | $17,281 | ||||||||
Gross profit margin | 30.0 | % | 25.0 | % | 39.4 | % | 29.8 | % |
Thirty-Nine Weeks Ended September 28, 2024 | ||||||||||||
Specialty Health Care | Engineering | Life Sciences and IT | Consolidated | |||||||||
Revenue | $101,668 | $70,180 | $29,620 | $201,468 | ||||||||
Cost of services | 71,672 | 52,818 | 18,769 | 143,259 | ||||||||
Gross profit | 29,996 | 17,362 | 10,851 | 58,209 | ||||||||
Gross profit margin | 29.5 | % | 24.7 | % | 36.6 | % | 28.9 | % |
Thirty-Nine Weeks Ended September 30, 2023 | ||||||||||||
Specialty Health Care | Engineering | Life Sciences and IT | Consolidated | |||||||||
Revenue | $99,553 | $61,956 | $30,700 | $192,209 | ||||||||
Cost of services | 70,623 | 47,482 | 19,039 | 137,144 | ||||||||
Gross profit | $28,930 | $14,474 | $11,661 | $55,065 | ||||||||
Gross profit margin | 29.1 | % | 23.4 | % | 38.0 | % | 28.6 | % |
RCM Technologies, Inc. Condensed Consolidated Balance Sheets (Unaudited) (In Thousands, Except Share Amounts) | ||||||
September 28, | December 30, | |||||
2024 | 2023 | |||||
(Unaudited) | ||||||
Current assets: | ||||||
Cash and cash equivalents | $3,156 | $6,284 | ||||
Accounts receivable, net of provision for credit losses of $1,600 at September 28, 2024 and December 30, 2023 | 75,913 | 70,690 | ||||
Transit accounts receivable | 6,315 | 8,891 | ||||
Prepaid expenses and other current assets | 5,112 | 4,637 | ||||
Total current assets | 90,496 | 90,502 | ||||
Property and equipment, net | 6,793 | 4,005 | ||||
Deposits | 215 | 313 | ||||
Deferred income taxes, foreign | 55 | 55 | ||||
Goodwill | 22,147 | 22,147 | ||||
Operating right of use asset | 5,292 | 2,779 | ||||
Intangible assets, net | 547 | 683 | ||||
Total other assets | 28,256 | 25,977 | ||||
Total assets | $125,545 | $120,484 |
Current liabilities: | ||||||
Accounts payable and accrued expenses | $11,525 | $12,454 | ||||
Transit accounts payable | 28,215 | 31,102 | ||||
Accrued payroll and related costs | 11,634 | 11,203 | ||||
Finance lease payable | 689 | 233 | ||||
Income taxes payable | 220 | 330 | ||||
Operating right of use liability | 1,019 | 693 | ||||
Contingent consideration from acquisitions | 300 | 300 | ||||
Deferred revenue | 2,042 | 1,881 | ||||
Total current liabilities | 55,644 | 58,196 | ||||
Deferred income taxes, net, foreign | 185 | 187 | ||||
Deferred income taxes, net, domestic | 1,719 | 1,568 | ||||
Finance lease payable, net of current position | 1,290 | - | ||||
Contingent consideration from acquisitions, net of current position | 1,671 | 1,671 | ||||
Operating right of use liability, net of current position | 4,519 | 2,268 | ||||
Borrowings under line of credit | 30,477 | 30,804 | ||||
Total liabilities | 95,505 | 94,694 | ||||
Contingencies (note 15) | - | - | ||||
Stockholders' equity: | ||||||
Preferred stock, $1.00 par value; 5,000,000 shares authorized; no shares issued or outstanding | - | - | ||||
Common stock, $0.05 par value; 40,000,000 shares authorized; 17,833,287 shares issued and 7,597,028 shares outstanding at September 28, 2024 and 17,673,427 shares issued and 7,844,821 shares outstanding at December 30, 2023 | 890 | 882 | ||||
Additional paid-in capital | 118,136 | 116,579 | ||||
Accumulated other comprehensive loss | (2,787 | ) | (2,813 | ) | ||
Accumulated deficit | (8,805 | ) | (19,265 | ) | ||
Treasury stock, 10,236,259 shares at September 28, 2024 and 9,828,606 shares at December 30, 2023, at cost | (77,394 | ) | (69,593 | ) | ||
Total stockholders' equity | 30,040 | 25,790 | ||||
Total liabilities and stockholders' equity | $125,545 | $120,484 |
RCM Technologies, Inc. Condensed Consolidated Statements of Cash Flows (Unaudited) (In Thousands) | ||||||
Thirteen Weeks Ended | ||||||
September 28, 2024 | September 30, 2023 | |||||
Net income | $2,746 | $3,756 | ||||
Adjustments to reconcile net income to cash used in operating activities | 1,508 | 1,049 | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | (9,033 | ) | 4,143 | |||
Prepaid expenses and other current assets | 321 | (987 | ) | |||
Net of transit accounts receivable and payable | 435 | 1,556 | ||||
Accounts payable and accrued expenses | (1,445 | ) | (785 | ) | ||
Accrued payroll and related costs | 1,919 | 2,790 | ||||
Right of use liabilities | (228 | ) | (333 | ) | ||
Income taxes payable | 81 | 15 | ||||
Deferred revenue | (636 | ) | (169 | ) | ||
Deposits | (12 | ) | 2 | |||
Total adjustments | (7,090 | ) | 7,281 | |||
Net cash (used in) provided by operating activities | ($4,344 | ) | $11,037 | |||
Net cash (used in) provided by investing activities | (522 | ) | 79 | |||
Net cash provided by (used in) financing activities | 4,375 | (11,343 | ) | |||
Effect of exchange rate changes on cash and cash equivalents | 167 | (392 | ) | |||
Decrease in cash and cash equivalents | ($324 | ) | ($619 | ) | ||
Common stock repurchase | ($2,410 | ) | ($3,389 | ) |
Thirty-Nine Weeks Ended | ||||||
September 28, 2024 | September 30, 2023 | |||||
Net income | $10,460 | $11,576 | ||||
Adjustments to reconcile net income to cash used in operating activities | 4,200 | 2,795 | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | (5,207 | ) | (6,696 | ) | ||
Prepaid expenses and other current assets | (475 | ) | (675 | ) | ||
Net of transit accounts receivable and payable | (311 | ) | 22,384 | |||
Accounts payable and accrued expenses | (760 | ) | (1,798 | ) | ||
Accrued payroll and related costs | 433 | 1,596 | ||||
Right of use liabilities | (686 | ) | (1,016 | ) | ||
Income taxes payable | (106 | ) | 162 | |||
Deferred revenue | 161 | (784 | ) | |||
Deposits | 98 | 4 | ||||
Total adjustments | (2,653 | ) | 15,972 | |||
Net cash provided by operating activities | 7,807 | 27,548 | ||||
Net cash used in investing activities | (1,589 | ) | (480 | ) | ||
Net cash used in financing activities | (9,135 | ) | (26,558 | ) | ||
Effect of exchange rate changes on cash and cash equivalents | (211 | ) | (195 | ) | ||
(Decrease) increase in cash and cash equivalents | ($3,128 | ) | $315 | |||
Common stock repurchase | ($7,801 | ) | ($24,449 | ) |
RCM Technologies, Inc. | Tel: 856.356.4500 | Corporate Contacts: |
2500 McClellan Avenue | ... | Bradley S. Vizi |
Pennsauken, NJ 08109 | Executive Chairman | |
Kevin D. Miller | ||
Chief Financial Officer | ||


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment